Skip to main content
Download PDF

FAM13A polymorphisms are associated with a specific susceptibility to clinical progression of oral cancer in alcohol drinkers

BMC Cancer volume 23, Article number: 607 (2023) Cite this article

Abstract

Background

Single nucleotide polymorphism (SNP) is a genetic variation that occurs when a single nucleotide base in the DNA sequence varies between individuals and is present in at least 1% of the population. Genetic variants in FAM13A are associated with different types of chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and lung cancer. However, there is little literature on the association of FAM13A genotypes with oral cancer. Therefore, this project will explore the correlation between the FAM13A genotype and the formation of oral cancer.

Methods

In this project, we will examine the presence of gene polymorphisms gene polymorphisms of rs1059122, rs3017895, rs3756050, and rs7657817 in the FAM13A gene exon, and combine the expression of these genes to try to clarify the impact of the FAM13A gene polymorphism on oral cancer. First, four loci (rs1059122, rs3017895, rs3756050, and rs7657817) of the FAM13A SNP were genotyped using TaqMan allelic discrimination.

Results

By estimating OR and AOR, FAM13A exhibited different genotypic variables in four SNPs that were not statistically significant between controls and patients with oral cancer. The results of the general analysis showed that different distributions of allelic types did not affect clinical stage, tumour size, lymph node invasion, distant metastasis, and pathological differentiation status. However, in the alcohol drinking group specifically, patients with the rs3017895 SNP G genotype had a 3.17-fold (95% CI, 1.102–9.116; p = 0.032) increase in the well differentiated state of cells compared to patients with the A allele.

Conclusions

Our results suggested that the SNP rs3017895 FAM13A could contribute to oral cancer. More sample studies are needed in the future to confirm our results and more functional studies are needed to investigate their relevant roles in the development of oral cancer.

Peer Review reports

Introduction

The 11th most malignant cancer in the world is oral cancer, which has affected patients' health for decades [1]. The most common histological type of oral cancer, accounting for more than 90% of cases, is oral squamous cell carcinoma (OSCC) [2]. The prognosis for OSCC is suboptimal due to the high incidence of recurrence and metastasis, with an average 5-year survival rate of approximately 50% after treatment strategies such as surgery, radiation therapy, and chemotherapy [3, 4]. The development of OSCC is associated with poor survival due to genetic and environmental risk factors, including chewing betel quid (BQ), smoking, and alcohol consumption [5]. However, genetic and environmental risk factors have a synergistic effect on the incidence of OSCC [6]. Numerous genetic variants, such as single nucleotide polymorphisms (SNPs), are associated with various types of cancer, and gene polymorphisms have been found to contribute to the complexity of genetic regulatory changes that contribute to SNP-related cancer susceptibility [7]. The strength of SNP arrays in identifying key genetic abnormalities in cancer could provide a method to reliably segment tumours based on shared genetic abnormalities, to obtain the most appropriate treatment for patients [8].

FAM13A (family with sequence similarity 13, member A) is also known to be located on chromosome 4q22 and plays a role in various cellular processes such as cytoskeletal organisation, cell migration, and signal transduction [9]. Previous studies clarified that the highest expression of the FAM13A gene was detected in the brain and ovary, followed by the presence of the FAM13A gene in the lung and kidney [10]. The protein encoded by this gene has two functions of the coiled-coil domain and the presence of three specific nuclear localisation signals [11]. Genome-wide association studies (GWAS) have identified several variants of FAM13A genes that are strongly associated with different types of chronic respiratory diseases, including chronic obstructive lung disease (COPD), pulmonary fibrosis (PF), asthma, and lung cancer [12,13,14,15]. Previous studies have illustrated that SNPs in the 3’untranslated region (UTR) and FAM13A exons are associated with an increased risk of lung squamous cell carcinoma (LUSQ) [14, 16]. Furthermore, the expression of FAM13A increased significantly in cirrhotic tissue cells, and analysis showed that the G-A haplotype of the gene rs3017895-rs1059122 contributed significantly to the risk of liver cirrhosis [17]. In particular, the association of FAM13A rs1059122 with a reduced risk of breast cancer in a recessive model may contribute to susceptibility to breast cancer in the Chinese Han population [18]. However, the relationship between oral cancer and SNPs is not well understood. Our study identified the FAM13A gene as a haplotype of four SNPs (rs1059122, rs3017895, rs3756050 and rs7657817) with 3' untranslated region (UTR) and exons. Our study investigates the relationship between SNPs and OSCC in Asian populations.

Materials and methods

Patients and samples

This study collected data on 290 oral cancer cases and 290 cancer-free cases over an eight-year period from 2013 to 2021. The study was awarded to the Institutional Review Board of Changhua Christian Hospital (CCH) and Changhua Christian Hospital Biobank (IRB No. 200211), indicating that ethical considerations were considered. The study also noted that clinical staging, lymph node metastasis, and tumour cell differentiation in oral squamous cell carcinoma (OSCC) were explained using the standard TNM staging system of the American Joint Committee on Cancer (AJCC). The TNM system is a widely accepted method to describe the extent of cancer in a patient and is used by physicians to guide treatment decisions and predict patient outcomes. It involves assessing the size and extent of the primary tumour (T), the involvement of nearby lymph nodes (N), and the presence of distant metastases (M). By using the system, the study can more accurately classify and compare oral cancer cases with cancer-free cases [19]. The definition of chewing and drinking classifies people according to whether they chew betel nuts or drink alcohol. In this case, people who chewed betel quid or drank alcohol would be classified as having positive binary outcomes for these behaviours, not necessarily at the time of the study or survey. Definitions classify individuals according to whether they have smoked at least one cigarette per day in the past 3 months, indicating that they have a smoking habit.

Genomic DNA extraction

Whole blood samples were collected during the hospitalisation of the patient and placed in sterile tubes containing EDTA. The collected samples were immediately centrifuged and stored at -80 °C. Genomic DNA was extracted from peripheral blood leukocytes using previously published methods using the QIAamp DNA Blood Mini Kit (Qiagen, Valencia, CA, USA) [20]. The extracts were dissolved in TE buffer (containing 10 mM trisaminomethane and 1 mM ethylenediaminetetraacetic acid; pH 7.8) and finally quantified by measuring optical density at a wavelength of 260 nm and stored at -20.

Real-time PCR

Real-time PCR, also known as quantitative PCR (qPCR), uses fluorescent probes to monitor the amplification of the target sequence in real time during the PCR reaction. When the probe binds to the target sequence, the polymerase cleaves the probe, which converts the reporter molecule to the quencher. The reagent molecules are separated, resulting in fluorescence. The quantitative fluorescent PCR instrument detects the fluorescence intensity in each cycle of the PCR reaction, to achieve the quantification of the target nucleic acid [21]. Three FAM13A gene polymorphisms (rs3017895, rs3756050, and rs7657817) were detected in a previous study with Genesky's proprietary improved Multiligase Detection Reaction (iMLDR) [14]. Furthermore, the polymorphism of the FAM13A gene rs1059122 has been significantly reported in cirrhosis risk disease [17]. However, the role of FAM13A polymorphisms in oral cancer is unclear. The study systematically selected four SNPs from the FAM13A gene polymorphism (rs1059122, rs3017895, rs3756050 and rs7657817), which were analysed using quantitative real-time PCR with the ABI StepOne real-time PCR System (Applied Biosystems, Foster City, CA, USA), and the data was analysed using StepOne software v2.3. The final volume of each reaction was 5 μL and the contents were 2.5 μL TaqMan Genotyping Master Mix, 0.125 μL TaqMan probe mix, and 30 ng of genomic DNA. Real-time PCR experiments were setup with an initial denaturation step at 95° C for 10 min, followed by 40 cycles of amplification at 95° C for 15 s and 60° C for 1 min. Polymorphisms of the FAM13A gene were assessed by PCR as previously described [22].

Bioinformatics analysis

This study aimed to analyse the association between the expression of the FAM13A gene and the clinical characteristics of head and neck squamous cell carcinoma (HNSCC) by downloading data from the Cancer Genome Atlas (TCGA) database through the University of California Santa Cruz (UCSC) Xena Functional Genomics Explorer, a web-based tool to explore and visualise genomic data. It is worth noting that users of the UCSC Xena Browser website ( https://xenabrowser.net/) [23] can access and analyse various genomic data sets through it. The article uses a browser search and retrieval of relevant TCGA data to analyse FAM13A gene expression and clinical features in HNSCC.

Statistical analysis

As in the previous study [24], the collected data were analysed for clinical characteristics using IBM SPSS Statistics v22.0 (IBM, Armonk, NY, USA). We used Mann-Whitney U validation to assess demographically significant differences between OSCC cases and noncancer controls, and further analysed the variation of FAM13A levels in TCGA's HNSCC dataset. Furthermore, logistic regression was used to determine the odds ratio (OR) distribution of the FAM13A SNP distribution in OSCC cases versus noncancer controls. Multiple regression was used to calculate adjusted odds ratios (AOR) with 95% confidence intervals (CI) for the FAM13A SNP distribution, while logistic regression was used to evaluate the SNP after adjustment for chewing, smoking, and alcohol consumption of betel quid. A significance level of p < 0.05 was used to determine statistical significance.

Results

Characteristics of the cohort

This study explores the collection and analysis of 290 OSCC patients and 290 cancer-free controls. The study found that there were no significant differences in age distribution between the control group (people without oral cancer) and OSCC patients (p = 0.0751). As for the gender distribution, the percentage showed significant difference between control group and the OSCC patients (p < 0.0001). It might due to the incidence rate of male is much higher than female [25]. However, the study found that chewing, smoking, and drinking were significantly different between the two groups. This suggests that these lifestyle habits may be associated with an increased risk of developing oral cancer. Based on the eighth edition of the AJCC and TNM staging scheme [26], the patients had primary tumour predistribution (68.3%), lymph node metastases (76.2%) and no distant organ metastases (93.8%). Furthermore, Table 1 shows that around 83.1% of OSCC cases had moderate to poor cellular differentiation.

Table 1 The distributions of demographical characteristics and clinical parameters in 290 controls and 290 cases with OSCC
Full size table

The polymorphism of the FAM13A gene can affect the occurrence and progression mechanism

To explore the distribution of FAM13A genotypes, four SNPs (rs1059122, rs3017895, rs3756050, and rs7657817) and clinical symptoms were separately analysed. The statistical analysis used was the estimation of the OR and its 95% CI using a logistic regression model. Additionally, we use personal habits (drinking, chewing nut beets, and smoking) as AOR as a secondary analysis target and incorporate different variables into the calculation results. We revealed, by estimating the OR and AOR, that FAM13A exhibited different genotypic variables in four SNPs that were not statistically significant between controls and patients with oral cancer, as shown in Table 2. We then further explored whether there is an association between different variants of SNP rs3017895 and specific characteristics of patients with OSCC, such as tumour size or lymph node involvement. By examining these relationships, we aim to determine whether the SNP could be used as a marker to predict the development and progression of OSCC. The results of this analysis would have been presented in Table 3, which likely lists the various categories of clinical and pathological characteristics that were studied. The study found that different variants (allele types) of SNP rs3017895 were not significantly associated with various clinicopathological characteristics such as clinical stage, tumour size, lymph node invasion, distant metastasis, metastasis, and pathological differentiation status of patients with OSCC. This means that the distribution of different types does not appear to have any effect on the development or progression of OSCC or tumour characteristics in patients with OSCC. The lack of a significant association suggests that this particular SNP may not be a useful marker to predict the severity of OSCC or the clinical outcome. To further explore whether drinking alcohol, chewing betel nuts, and smoking are considered risk factors for SNP rs3017895 and OSCC, we calculated the correlation between patients with different genotypes. Our study indicated that subjects who chewed betel quid and smoked were not associated with clinical stage, tumour size, lymph node metastasis, distant metastasis, or cell differentiation status FAM13A SNP subgroup rs3017895. Especially in the alcohol drinking group, patients with the SNP G genotype were found to have a 3.17-fold increase in the highly differentiated state of cells (95% CI, 1.102-9.116; p = 0.032) and a significantly lower incidence of distant metastases (95% CI, 0.056-0.876; p = 0.032) compared to patients with the A allele, as shown in Table 4. The above results suggest that the characteristics of patients with different habits are associated with FAM13A SNP and environmental risk and oral cancer progression.

Table 2 Distribution of genotype frequencies in FAM13A SNPs in cases of OSCC group
Full size table
Table 3 Clinical status and FAM13A rs3017895 genotype frequencies in cases of the OSCC group
Full size table
Table 4 Clinical statuses and frequencies of FAM13A rs3017895 genotypes in cases of the OSCC group among chewing betel nut, smoking and drinking alcohol
Full size table

Clinical and Functional Insights from FAM13A to OSCC

Previous studies have shown a genetic association between FAM13A and oral cancer, and we explore the clinical features of this gene using the TCGA dataset, as shown in Fig. 1. We did not observe significant differences in the FAM13A gene between various clinical characteristics, including clinical stage (p = 0.1371), tumour (p = 0.6249), and lymph node metastasis (p = 0.1923). However, we did find that the cell differentiation status was significantly different between the good and poor status (p = 0.0132), as well as between the intermediate and poor status (p = 0.0105). These findings suggest that the degree of cell differentiation may be a more important predictor of severity and clinical outcome than the expression of the FAM13A gene.

Fig. 1
figure 1

The purpose of the study was to explore the potential relationship between the expression level of the FAM13A gene and various clinicopathological parameters in cases of HNSCC. The relationship between the expression of the FAM13A gene and different aspects of HNSCC was investigated using data from the TCGA database. Specifically, the study examined the correlation between FAM13A expression and clinical stage (A), tumour size (B), lymph node metastasis (C), and cell differentiation (D) in HNSCC. Results with a p-value of less than 0.05 were considered statistically significant

Full size image

Discussion

Humans have a very high degree of genetic similarity, with over 99% identity in their genome sequence. This means that differences between individuals are typically due to variations in small sections of their DNA, such as tandem repeats, insertion or deletion polymorphisms, and single nucleotide polymorphisms (SNPs). These variations account for less than 1% of the overall genetic material and contribute to the diversity of the human population [27]. GWAS have identified specific SNPs that are associated with the development of cancer and its various characteristics. Cancer Genome Atlas (TCGA) has also shown that there are differences in DNA sequence between tumour cells and normal cells [28, 29]. SNPs have a highly modulated susceptibility to disease by the interaction of human exposure to environmental factors and specific allelic variants. Several conclusions about gene-environment interactions illuminate their combined impact on human cancer incidence and/or prevalence [30]. Together, these findings suggest that genetic variations play an important role in cancer development and progression and may provide information on potential targets for diagnosis, treatment, and prevention.

Oral cancer is a common and serious health problem. Smoking and alcohol consumption are considered major factors in the development of oral cancer and are among the leading causes of death related to this disease [31]. As noted in previous studies, several studies have demonstrated familial clustering, suggesting a role for genetic components in the development of oral cancer [32]. High genetic influence can lead to the development of up to 10% of cancers. There has been much recent research evidence showing the association between oral cancer and SNPs in different genes. Exploring specific genetic polymorphisms of key genes related to oral carcinogenesis has been a major area of research. Polymorphisms in glutathione S-transferase (GST) genes (GSTM1, GSTT1, and GSTP1) and their interaction with environmental factors such as tobacco and alcohol influence susceptibility to HNSCC [33]. Singh et al. demonstrated that alcohol consumption resulted in a four-fold increase in risk in patients with GSTM1 null genotype compared to non-drinkers [34]. The CYP1A1 gene encodes an aromatic hydrocarbon hydroxylase that induces the biotransformation of aromatic tobacco carcinogens and may play a key role in the pathogenesis of oral squamous cell carcinoma (OSCC) through the MspI polymorphism. The MspI SNP in the CYP1A1 gene indicated a 34% increased risk of head and neck cancer in carriers of the TC and CC genotype compared to carriers of carriers of TT carriers [35]. The main enzymes involved in alcohol metabolism are alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH), and noncoding variants of the ADH and ALDH genes can also affect alcohol metabolism [36]. It is becoming increasingly clear that null ALDH alleles lead to elevated acetaldehyde levels and are believed to increase the risk of head and neck cancer [37].

Previous studies have confirmed a relationship between FAM13A SNPs and various cancers, such as non-small cell lung cancer, renal cell carcinoma, cervical cancer, and breast cancer [12, 18, 38, 39]. The results of this study indicate a significant difference in the SNP located in the FAM13A gene between oral cancer patients and the control group. We first explored individual habit-adjusted odds ratios, which did not differ significantly between the control and OSCC patient groups. This result suggests that an individual's personal lifestyle habits and their genetic makeup, particularly the FAM13A variant rs3017895, may play an important role in the development of oral cancer. Our analysis is consistent with previous research that has shown a correlation between the minor G allele of the FAM13A variant rs3017895 and an increased susceptibility to lung cancer among the Han Chinese Han population [14]. Follow-up studies are needed with larger control and patient groups to confirm the importance of FAM13A SNP rs3017895 in oral cancer. Therefore, further analysis will be performed on the FAM13A variant rs3017895.

Numerous studies have shown that personal habits, such as drinking, smoking, and chewing betel nuts, are strongly associated with the development of oral cancer [40,41,42]. However, when comparing the effects of different alleles on personal habits, only alcohol consumption showed a statistically significant difference. Furthermore, the association between alcohol consumption and oral cancer is multifactorial and is influenced by various factors, including genetics, lifestyle habits, and environmental exposure. The enzymes involved in alcohol metabolism are mainly ADH and ALDH, and noncoding variants of ADH and ALDH genes may also affect alcohol metabolism. In particular, slow ethanol metabolism has been associated with an increased risk of head and neck cancer, particularly in people who slowly metabolise alcohol slowly [43]. Previous studies have shown that COPD genome-wide association studies have identified genetic risk variants in FAM13A [44]. Alcohol contributes to co-carcinogenesis or contributes to carcinogenesis, especially acetaldehyde, which has been shown to alter DNA-associated epigenetic alterations in head and neck cancer [45, 46]. Therefore, we investigated the relationship between the FAM13A rs3017895 polymorphism and personal habits, as well as clinical status, in patients with oral cancer. Especially in patients with alcohol consumption, the highly differentiated state of cells in patients with the G genotype increased 3.17 times (95% CI, 1.102–9.116) compared to patients with the SNP A genotype rs3017895. Consistent with the above studies, we demonstrate that FAM13A polymorphisms have strong effects and significant differences in the susceptibility of oral cancer to alcohol consumption. In general, our findings suggest that SNP FAM13A rs3017895 may be a key factor in predicting tumour recurrence, target therapy response, and drug toxicity in patients with oral cancer. More research is needed to better understand the correlation between this SNP and other common somatic genetic changes in oral cancer.

Conclusions

Based on the experimental results, it has been confirmed that there is an association between the SNP rs3017895 located in the FAM13A gene and the development of OSCC, as well as poorer clinical stage in patients with OSCC. This suggests that this specific genetic variation may be a potential biomarker of OSCC and could be useful to identify people who may be at increased risk of developing the disease or to monitor the progression of the disease in patients with OSCC. Especially in the drinking group, it was found that patients with the SNP G genotype had a 3.17-fold increase in the state of highly differentiated cells and a significantly lower incidence of distant metastasis compared to patients with the A allele. Finally, the role of the FAM13A SNP provides evidence for further investigation of the utility of the genetic marker in diagnosis and prevention.

Availability of data and materials

The datasets generated during and analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Lin NC, Hsien SI, Hsu JT, Chen MYC. Impact on patients with oral squamous cell carcinoma in different anatomical subsites: a single-center study in Taiwan. Sci Rep. 2021;11(1):15446.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Li C, Chen X, Ren X, Chen JL, Chen H, Yu JJ, Ran QC, Kang S, Chen XM, Zhao ZJ. Identification of Hypoxia-Related Molecular Classification and Associated Gene Signature in Oral Squamous Cell Carcinoma. Front Oncol. 2021;11:709865.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Taghavi N, Yazdi I. Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Arch Iran Med. 2015;18(5):314–9.

    PubMed  Google Scholar 

  4. Bavle RM, Venugopal R, Konda P, Muniswamappa S, Makarla S. Molecular Classification of Oral Squamous Cell Carcinoma. J Clin Diagn Res. 2016;10(9):ZE18–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Messadi DV. Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci. 2013;5(2):59–65.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chung CM, Lee CH, Chen MK, Lee KW, Lan CE, Kwan AL, Tsai MH, Ko YC. Combined Genetic Biomarkers and Betel Quid Chewing for Identifying High-Risk Group for Oral Cancer Occurrence. Cancer Prev Res (Phila). 2017;10(6):355–62.

    Article  CAS  PubMed  Google Scholar 

  7. Deng N, Zhou H, Fan H, Yuan Y. Single nucleotide polymorphisms and cancer susceptibility. Oncotarget. 2017;8(66):110635–49.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Heinrichs S, Look AT. Identification of structural aberrations in cancer by SNP array analysis. Genome Biol. 2007;8(7):219.

    Article  PubMed  PubMed Central  Google Scholar 

  9. van Moorsel CHM. Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2018;24(3):309–17.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ziolkowska-Suchanek I, Mosor M, Gabryel P, Grabicki M, Zurawek M, Fichna M, Strauss E, Batura-Gabryel H, Dyszkiewicz W, Nowak J. Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases. Sci Rep. 2015;5:13502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Cohen M, Reichenstein M, Everts-van der Wind A, Heon-Lee J, Shani M, Lewin HA, Weller JI, Ron M, Seroussi E. Cloning and characterization of FAM13A1–a gene near a milk protein QTL on BTA6: evidence for population-wide linkage disequilibrium in Israeli Holsteins. Genomics. 2004;84(2):374–83.

    Article  CAS  PubMed  Google Scholar 

  12. Eisenhut F, Heim L, Trump S, Mittler S, Sopel N, Andreev K, Ferrazzi F, Ekici AB, Rieker R, Springel R, et al. FAM13A is associated with non-small cell lung cancer (NSCLC) progression and controls tumor cell proliferation and survival. Oncoimmunology. 2017;6(1):e1256526.

    Article  PubMed  Google Scholar 

  13. Hirano C, Ohshimo S, Horimasu Y, Iwamoto H, Fujitaka K, Hamada H, Hattori N, Shime N, Bonella F, Guzman J, et al. FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis. Respir Med. 2017;123:105–9.

    Article  PubMed  Google Scholar 

  14. Yu Y, Mao L, Lu X, Yuan W, Chen Y, Jiang L, Ding L, Sang L, Xu Z, Tian T, et al. Functional Variant in 3’UTR of FAM13A Is Potentially Associated with Susceptibility and Survival of Lung Squamous Carcinoma. DNA Cell Biol. 2019;38(11):1269–77.

    Article  CAS  PubMed  Google Scholar 

  15. Zhu J, Wang F, Feng X, Li B, Ma L, Zhang J. Family with sequence similarity 13 member A mediates TGF-beta1-induced EMT in small airway epithelium of patients with chronic obstructive pulmonary disease. Respir Res. 2021;22(1):192.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Young RP, Hopkins RJ, Hay BA, Whittington CF, Epton MJ, Gamble GD. FAM13A locus in COPD is independently associated with lung cancer - evidence of a molecular genetic link between COPD and lung cancer. Appl Clin Genet. 2011;4:1–10.

    PubMed  Google Scholar 

  17. Zhang Y, Wang S, Wang C, Xiao J, Zhang S, Zhou H. High expression of FAM13A was associated with increasing the liver cirrhosis risk. Mol Genet Genomic Med. 2019;7(3):e543.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Wei Y, Wang X, Zhang Z, Xie M, Li Y, Cao H, Zhao X. Role of Polymorphisms of FAM13A, PHLDB1, and CYP24A1 in Breast Cancer Risk. Curr Mol Med. 2019;19(8):579–88.

    Article  CAS  PubMed  Google Scholar 

  19. Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–37.

    Article  PubMed  Google Scholar 

  20. Lu HJ, Chuang CY, Chen MK, Su CW, Yang WE, Yeh CM, Lai KM, Tang CH, Lin CW, Yang SF. The impact of ALDH7A1 variants in oral cancer development and prognosis. Aging (Albany NY). 2022;14(10):4556–71.

    Article  CAS  PubMed  Google Scholar 

  21. Mackay IM. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect. 2004;10(3):190–212.

    Article  CAS  PubMed  Google Scholar 

  22. Hua KT, Liu YF, Hsu CL, Cheng TY, Yang CY, Chang JS, Lee WJ, Hsiao M, Juan HF, Chien MH, et al. 3’UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma. Sci Rep. 2017;7(1):4466.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Shieu MK, Ho HY, Lin SH, Lo YS, Lin CC, Chuang YC, et al. Association of KMT2C genetic variants with the clinicopathologic development of oral cancer. Int J Environ Res Public Health. 2022;19(7):3974–83.

  25. Wang EY, Chen MK, Hsieh MY, Kor CT, Liu YT. Relationship between preoperative nutritional status and clinical outcomes in patients with head and neck cancer. Nutrients. 2022;14(24):5331–44.

  26. Huang SH, O’Sullivan B. Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Curr Treat Options Oncol. 2017;18(7):40.

    Article  PubMed  Google Scholar 

  27. Robert F, Pelletier J. Exploring the Impact of Single-Nucleotide Polymorphisms on Translation. Front Genet. 2018;9:507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Srinivasan S, Clements JA, Batra J. Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer? Crit Rev Clin Lab Sci. 2016;53(1):29–39.

    Article  CAS  PubMed  Google Scholar 

  29. Stadler ZK, Thom P, Robson ME, Weitzel JN, Kauff ND, Hurley KE, Devlin V, Gold B, Klein RJ, Offit K. Genome-wide association studies of cancer. J Clin Oncol. 2010;28(27):4255–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Mbemi A, Khanna S, Njiki S, Yedjou CG, Tchounwou PB. Impact of gene-environment interactions on cancer development. Int J Environ Res Public Health. 2020;17(21):8089–103.

  31. Ram H, Sarkar J, Kumar H, Konwar R, Bhatt ML, Mohammad S. Oral cancer: risk factors and molecular pathogenesis. J Maxillofac Oral Surg. 2011;10(2):132–7.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Jefferies S, Eeles R, Goldgar D, A’Hern R, Henk JM, Gore M. The role of genetic factors in predisposition to squamous cell cancer of the head and neck. Br J Cancer. 1999;79(5–6):865–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Katiyar T, Yadav V, Maurya SS, Ruwali M, Singh M, Hasan F, Pandey R, Mehrotra D, Singh S, Mishra S, et al. Interaction of glutathione-s-transferase genotypes with environmental risk factors in determining susceptibility to head and neck cancer and treatment response and survival outcome. Environ Mol Mutagen. 2020;61(5):574–84.

    Article  CAS  PubMed  Google Scholar 

  34. Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res. 2008;638(1–2):184–94.

    Article  CAS  PubMed  Google Scholar 

  35. Liu L, Wu G, Xue F, Li Y, Shi J, Han J, Zhang X, Na Y, Zhang H, Tang X, et al. Functional CYP1A1 genetic variants, alone and in combination with smoking, contribute to development of head and neck cancers. Eur J Cancer. 2013;49(9):2143–51.

    Article  CAS  PubMed  Google Scholar 

  36. Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health. 2007;30(1):5–13.

    PubMed  PubMed Central  Google Scholar 

  37. Brennan P, Lewis S, Hashibe M, Bell DA, Boffetta P, Bouchardy C, Caporaso N, Chen C, Coutelle C, Diehl SR, et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol. 2004;159(1):1–16.

    Article  PubMed  Google Scholar 

  38. Wang XJ, Li S, Fang J, Yan ZJ, Luo GC. LncRNA FAM13A-AS1 Promotes Renal Carcinoma Tumorigenesis Through Sponging miR-141-3p to Upregulate NEK6 Expression. Front Mol Biosci. 2022;9:738711.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Qiu Z, He L, Yu F, Lv H, Zhou Y. LncRNA FAM13A-AS1 Regulates Proliferation and Apoptosis of Cervical Cancer Cells by Targeting miRNA-205-3p/DDI2 Axis. J Oncol. 2022;2022:8411919.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Jiang X, Wu J, Wang J, Huang R. Tobacco and oral squamous cell carcinoma: A review of carcinogenic pathways. Tob Induc Dis. 2019;17:29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Turati F, Garavello W, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, Corrao G, Boffetta P, La Vecchia C, et al. A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: results by subsites. Oral Oncol. 2010;46(10):720–6.

    Article  PubMed  Google Scholar 

  42. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 1995;24(10):450–3.

    Article  CAS  PubMed  Google Scholar 

  43. Huang CC, Hsiao JR, Lee WT, Lee YC, Ou CY, Chang CC, Lu YC, Huang JS, Wong TY, Chen KC, et al. Investigating the Association between Alcohol and Risk of Head and Neck Cancer in Taiwan. Sci Rep. 2017;7(1):9701.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet. 2010;42(3):200–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Viswanathan H, Wilson JA. Alcohol–the neglected risk factor in head and neck cancer. Clin Otolaryngol Allied Sci. 2004;29(4):295–300.

    Article  CAS  PubMed  Google Scholar 

  46. Werbrouck J, De Ruyck K, Duprez F, Van Eijkeren M, Rietzschel E, Bekaert S, Vral A, De Neve W, Thierens H. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption. Mutat Res. 2008;656(1–2):74–81.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was funded by the Changhua Christian Hospital, Changhua City, Taiwan (109-CCH-PRJ-002). We would like to thank the Changhua Christian Hospital Biobank and Dr. Yu-Jun Chang (Big Data Center, Changhua Christian Hospital) for providing the biological specimen and related clinical data for our research. The authors of the manuscript do not have a direct financial relationship with the commercial identity mentioned in this paper.

Funding

This research received no external funding.

Author information

Authors and Affiliations

  1. Oral Cancer Research Center, Changhua Christian Hospital, Changhua, 500, Taiwan

    Ming-Ju Hsieh, Yu-Sheng Lo, Hsin-Yu Ho, Chia-Chieh Lin & Yi-Ching Chuang

  2. Program in Tissue Engineering and Regenerative Medicine, College of Medicine, National Chung Hsing University, Taichung, 402, Taiwan

    Ming-Ju Hsieh

  3. Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 404, Taiwan

    Ming-Ju Hsieh

  4. Department of Surgical Pathology, Changhua Christian Hospital, Changhua, 500, Taiwan

    Yun-Jung Tsai & Shu-Hui Lin

  5. Translational Pathology Core Laboratory, Changhua Christian Hospital, Changhua, 500, Taiwan

    Yun-Jung Tsai & Shu-Hui Lin

  6. Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, 406, Taiwan

    Shu-Hui Lin

  7. Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, No.135, Nanxiao St., Changhua City, Changhua County, 500, Taiwan

    Mu-Kuan Chen

  8. Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, 402, Taiwan

    Mu-Kuan Chen

Authors
  1. Ming-Ju Hsieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu-Sheng Lo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yun-Jung Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hsin-Yu Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chia-Chieh Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yi-Ching Chuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shu-Hui Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mu-Kuan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization, M.J.H., S.H.L. and M.K.C.; Methodology, Y.J.T., H.Y.H., C.C.L., Y.S.L. and Y.C.C.; Software, Y.J.T., H.Y.H., C.C.L., Y.S.L. and Y.C.C.; Writing—Original draft preparation, M.J.H. and Y.S.L.; Writing—Review and Editing, M.J.H. and M.K.C. All authors reviewed the manuscript.

Corresponding author

Correspondence to Mu-Kuan Chen.

Ethics declarations

Ethics approval and consent to participate

This study's protocol was approved by the Institutional Review Board (IRB) of the Changhua Christian Hospital and the Changhua Christian Hospital Biobank (Changhua, Taiwan; IRB No. 200211, date of approval Mar. 13, 2022). All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by Institutional Review Board (IRB) of the Changhua Christian Hospital. Informed consent was obtained from all subjects and/or their legal guardians.

Consent for publication

Not applicable.

Competing interests

The authors declare no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hsieh, MJ., Lo, YS., Tsai, YJ. et al. FAM13A polymorphisms are associated with a specific susceptibility to clinical progression of oral cancer in alcohol drinkers. BMC Cancer 23, 607 (2023). https://doi.org/10.1186/s12885-023-11052-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-023-11052-5

Keywords

BMC Cancer

ISSN: 1471-2407

Contact us